2 completed, 1 active not recruiting, 1 recruiting. 4 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Active not recruiting 1, Recruiting 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Pancreatic surgery: new trials by email Literature Review of Pancreatic surgery trials Research Report on Pancreatic surgery
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer Biopsy, Biospecimen Collection, Cisplatin - Borderline Resectable Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Adenocarcinoma | Phase 2 | Recruiting | Georgetown University | 36 | 2024-08-06 | 2026-09-30 |
| Nordic Pancreatic Cancer Trial (NorPACT) - 1 5-FU, Oxaliplatine, Irinotecan - Pancreatic Cancer | Phase 2 / Phase 3 | Active not recruiting | Oslo University Hospital | 140 | 2016-09-01 | 2024-11-20 |
| Perioperative Therapy for Resectable Pancreatic Cancer gemcitabine hydrochloride, docetaxel, capecitabine - Adenocarcinoma of the Pancreas, Stage IA Pancreatic Cancer | Phase 2 | Completed | University of Washington | 35 | 2008-01-01 | 2017-07-13 |
| Chemotherapy and Radiation Following Pancreatic Surgery Pancreatic Surgery, Radiation therapy, Cisplatin - Pancreatic Cancer | Phase 2 | Completed | Washington University School of Medicine | 53 | 2002-05-01 | 2013-04-23 |
Georgetown University (1) · Oslo University Hospital (1) · University of Washington (1) · Washington University School of Medicine (1)
United States (3) · Denmark (1) · Finland (1) · Norway (1) · Sweden (1)
Andrew Coveler (1) · David Linehan, MD (1) · Knut Jorgen Labori, MD PhD (1) · Mihir M. Shah, MD, MS, FACS, FSSO (1)
PMID 18650621, PMID 28841916, PMID 38237621
2015 (1), P30CA015704 (1)